Similar Keywords
invasive breast cancer risk
See Your Featured Site Here For Just $0.25 a Month.
Sites
EVISTA® (raloxifene HCl): Osteoporosis and Invasive Breast Cancer
Information about osteoporosis and invasive breast cancer and how to reduce the risks for both with EVISTA® (raloxifene HCl), a prescription medication for postmenopausal women with osteoporosis. www.evista.com · bookmarked by 1 member · added at Fri, 12 Dec 2008
Site Details
evista
·
evista raloxifene
·
osteoporosis treatment
·
invasive breast cancer
·
bone health
·
osteoporosis prevention
·
bone loss prevention
·
raloxifene
·
invasive breast cancer risk
·
postmenopausal women
·
postmenopausal woman
|